Longwood Healthcare Leaders to Bring Together Several Hundred Top Biotech and Pharmaceutical Leaders on Jan. 5-6, 2023

BOSTON, November 30, 2022 (Newswire.com) - Longwood Fund, an early-stage life science venture firm, will convene several hundred top biotech and pharmaceutical leaders at its Pre-JPM Longwood Healthcare Leaders meeting, hosted virtually via webconference, on Jan. 5-6, 2023.

The meeting focuses on a broad spectrum of topics affecting the biopharma ecosystem. Biopharma CEOs and C-suite executives, heads of R&D, therapeutic area heads, top academics, and life science investors will join off-the-record discussions of ideas, strategies, and insights to help the industry translate groundbreaking discoveries into medicines to help patients.

Hosted by Longwood Fund, industry leaders will speak in moderated keynotes, fireside chats, and discussion panels: FDA CBER Director Peter Marks, Stanford President Marc Tessier-Lavigne and Stanford Medical School Dean Lloyd Minor, Pfizer CSO and President of Worldwide Research, Development and Medical Mikael Dolsten, Genentech CEO Alexander Hardy, Eisai Inc. CEO Ivan Cheung, Sanofi head of R&D John Reed, Novartis Institutes for BioMedical Research President Fiona Marshall, Bristol Myers Squibb President of Research and Early Development Rupert Vessey, Roche CMO Levi Garraway, Compass Pathways CEO Kabir Nath, Janssen Global Head of Public Health R&D Ruxandra Draghia Akli, Bayer Pharma R&D head Christian Rommel, Moderna scientific co-founder Bob Langer, Ovid CEO Jeremy Levin, Cystic Fibrosis Foundation CEO Mike Boyle, AbbVie Chief Strategy Officer Henry Gosebruch, Takeda CSO Steve Hitchcock, Novartis global oncology head Shiva Malek, former Alnylam CEO John Maraganore, Mass General Brigham CEO Anne Klibanski, former FDA Commissioner Steve Hahn, Sanofi CSO Frank Nestle, Janssen R&D Chief Data Science Officer Najat Khan, Global Blood Therapeutics CEO Ted Love, Vigil Neuroscience CEO Ivana Magovcevic-Liebisch, Sage Therapeutics CEO Barry Greene, ArsenalBio CEO Ken Drazan, Ginkgo Bioworks CEO Jason Kelly, Amgen BD head Rachna Khosla, Janssen global BD head Nauman Shah, AstraZeneca global oncology head Sunil Verma, among others.

Topics discussed include launching and building biotech companies, big biopharma R&D, sourcing and identifying novel technology, the future of diagnostics, harnessing biomedical innovation, navigating regulatory challenges, drug approvals, RNAi technology and innovation, and raising and managing capital, among others.

Profits from the meeting benefit various charities, Life Science Cares, The Boston Foundation, Harvard Medical School, MIT, and others. Registered participants are invited to join a cocktail reception at the new Longwood Fund office in Boston's Prudential Tower on the opening day of the meeting. To learn more, visit www.longwoodhealthcareleaders.com/prejpm.

Longwood Healthcare Leaders

Longwood Healthcare Leaders meetings bring together leading biotech and pharma CEOs, heads of R&D, top academics, and healthcare investors for off-the-record discussions to drive transparency and collaboration to accelerate the translation of discoveries into medicines to help patients. 

Source: Longwood Healthcare Leaders